CADILAHC(Cadila Healthcare Limited)
04.02.2022 - Jefferies on CADILA Maintain Hold CMP 407 Target 439(PREV TGT 490)
04.02.2022 - Nomura on CADILA Maintain Buy CMP 407 Target 489
04.02.2022 - MS on CADILA Maintain Overweight CMP 407 Target 543
CLSA ON CADILA HEALTHCARE : 28.05.2021
* Cut rating from BUY to Outperform, Target at Rs 670/share
* A neat 10% beat on Ebitda; large tax writeback drives bigger beat on net profit
* Strong quarter for domestic business but weak print for export sales
* Long-term growth story intact given R&D initiatives; Recent 44% rally and margin pressure to cap significant upside
We(rupeedesk.in) are SEBI Registered leading Indian Stock Market Trading Tips Providers for Equity,Commodity and currency market traded in NSE,BSE,MCX,NCDEX And MCXSX.USDINR,EURINR,GBPINR,JPYINR,Dollar,Euro,Pound,Yen currencies.Indian Currency futures and Options Trading Tips. . Free Currency Tips|Stock and Nifty Options Tips| Commodity Tips |Intraday Tips Register Here : 91-9094047040 |91-9841986753|044-24333577
Tuesday, February 22, 2022
CADILAHC
ERIS
ERIS(Eris Lifesciences Ltd) 18.01.2023 - Macquarie on ERIS Maintain Outperform CMP 625.75 Target 830